{rfName}
Ev

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Cortés-Bullich, AlbertAuthorGuijarro, FrancescaAuthorMartinez-Roca, AlexandraAuthorJimenez-Vicente, CarlosAuthorRosinol, LauraAuthorUrbano-Ispizua, AlvaroAuthorMartinez, CarmenAuthorEsteve, JordiAuthorRovira, MontserratAuthorDiaz-Beya, MarinaAuthorQueralt Salas, MariaAuthor

Share

Publications
>
Meeting Abstract

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

Publicated to:Blood. 142 - 2023-11-29 142(), DOI: 10.1182/blood-2023-181076

Authors: Tolosa-Ridao, Carles; Charry, Paola; Castano-Diez, Sandra; Suarez-Lledo, Maria; Merchan Munoz, Beatriz; Esteban, Daniel; Cortes-Bullich, Albert; Guijarro, Francesca; Teresa Solano, Maria; Martinez-Roca, Alexandra; Jimenez-Vicente, Carlos; Rosinol, Laura; Carreras, Enric; Urbano-Ispizua, Alvaro; Fernandez-Aviles, Francesc; Martinez, Carmen; Esteve, Jordi; Rovira, Montserrat; Diaz-Beya, Marina; Queralt Salas, Maria

Affiliations

Hosp Clin Barcelona, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Hematol, ICMHO, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Pathol, Hematopathol Unit, Barcelona, Spain - Author
Hosp Clin Barcelona, Hematopoiet Cell Transplantat Unit, ICHMO, Barcelona, Spain - Author
Hosp Univ Mutua Terrassa, Dept Hematol, Terrassa, Spain - Author
Josep Carreras Fdn, Barcelona, Spain - Author
Leukemia Res Inst, Barcelona, Spain - Author
See more

Abstract

Keywords

Astronomia / físicaBiochemistryBiodiversidadeBiotecnologíaCell biologyCiências ambientaisCiências biológicas iCiências biológicas iiCiências biológicas iiiEngenharias ivFarmaciaGeneral medicineHematologyImmunologyInterdisciplinarMedicina iMedicina iiMedicina iiiSaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Blood due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 2/97, thus managing to position itself as a Q1 (Primer Cuartil), in the category Hematology. Notably, the journal is positioned above the 90th percentile.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (Salas Gay, María Queralt).